Pharmaceutical preparations, namely, anti-cancer and immunosuppression preparations; pharmaceuticals, namely, anti-cancer and immunosuppression preparations; chemico-pharmaceutical preparations, namely, chemical preparations for medical purposes for the treatment of cancer and immunosuppression; pharmaceutical preparations and substances, namely, pharmaceutical products for the treatment of cancer and immunosuppression; pharmaceutical preparations, namely, anti-cancer preparations for veterinary use; chemical preparations for pharmaceutical purposes, namely, chemical preparations for the treatment of cancer and immunosupression; pharmaceutical preparations for human use, namely, pharmaceutical preparations for human use in the treatment of cancer and immnunosupression; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in chemotherapy; pharmaceutical preparations for the treatment of cancer and immunosuppression; pharmaceutical preparations and substances for the treatment of cancer and immunosuppression; pharmaceutical preparations and substances for use in oncology; diagnostic preparations for medical purposes; diagnostic agents for pharmaceutical use; diagnostic agents for medical use; diagnostic preparations for veterinary purposes; clinical diagnostic reagents for medical use; diagnostic chemical reagents for medical use; anti-cancer drugs, namely, anti-cancer preparations; pharmaceutical compounds for treating cancer and immunosuppression; anti-cancer preparations; anti-cancer preparations of chemical origin; biopharmaceuticals, namely, anti-cancer preparations for the treatment of cancer and immunosuppression; pharmaceutical preparations and substances for the prevention of cancer; chemotherapeutics; antibodies being pharmaceutical preparations for the treatment of cancer and immunosuppression; all the aforesaid goods exclusively relating to the fields of oncology and/or immunosuppression with agents including amatoxin

Class [042]
Computer & Software Services & Scientific Services

Pharmaceutical research services; medical and pharmacological research services; pharmaceutical products development; development of pharmaceutical preparations and medicines; consultancy relating to pharmaceutical research and development; provision of medical research services; scientific research; medical research; biomedical research services; research relating to biotechnology; research on the subject of pharmaceuticals; consultancy relating to research in the field of pharmacogenetics; research and development in the pharmaceutical and biotechnology fields; research and development in the field of diagnostic preparations; research and development in the field of biotechnology; pharmaceutical research and development for the pharmaceutical industry; research and development services in the field of antibody technology; research and development services in the field of antibodies; scientific laboratory services relating to the production of monoclonal antibodies; all the aforesaid goods exclusively relating to the fields of oncology and/or immunosuppression

Class [044]
Medical, Beauty & Agricultural Services

Pharmaceutical advice; pharmaceutical consultation services; consultancy and information services relating to pharmaceutical products; all the aforesaid goods exclusively relating to the fields of oncology and/or immunosuppression

Mark Details

Serial Number

No 88439354

Mark Type

No Service Mark

Attorney Docket Number

No 13318.1008US

44D Filed

44D Current

44E filed

44E Current

66A Filed

66A Current

Current Basis

No Basis

Legal History

Status Date	Action Taken
01^st Nov 2022	NOTICE OF REGISTRATION CONFIRMATION EMAILED
01^st Nov 2022	REGISTERED-PRINCIPAL REGISTER
16^th Aug 2022	OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
16^th Aug 2022	PUBLISHED FOR OPPOSITION
27^th Jul 2022	NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08^th Jul 2022	APPROVED FOR PUB - PRINCIPAL REGISTER
06^th Jul 2022	TEAS/EMAIL CORRESPONDENCE ENTERED
05^th Jul 2022	CORRESPONDENCE RECEIVED IN LAW OFFICE
05^th Jul 2022	TEAS REQUEST FOR RECONSIDERATION RECEIVED
13^th Jan 2022	NOTIFICATION OF FINAL REFUSAL EMAILED

ATAC

Classification Information

Class [005]Pharmaceutical Products

Class [042]Computer & Software Services & Scientific Services

Class [044]Medical, Beauty & Agricultural Services